NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

Out of curiosity, in testing the FlaskWork device, do people here believe that they use patients who's tumor is sufficient to make two batches of the vaccine, one made in a clean room, the other by FlaskWork and comparing the two. I wonder if these patients are getting the vaccine under compassionate use, and paying for it, or if it's considered a trial, where the company is paying. In terms of what the patient receives, until the FlaskWork is deemed to be acceptable, I'd think they'd receive the conventionally made vaccine.

I believe the company is all in for FlaskWork's and planning for commercial production that's totally reliant on it. That said, I do believe they'll certify sufficient clean room capability to gain approvals even if FlaskWork is delayed. I still believe that CRL is the key to using a massive number of clean rooms, but in time they'll also have an arrangement for the FlaskWork device once it's approved.

Gary